ALX Oncology Holdings Inc. (ALXO): Price and Financial Metrics
ALXO Price/Volume Stats
| Current price | $1.65 | 52-week high | $17.83 |
| Prev. close | $1.66 | 52-week low | $1.19 |
| Day low | $1.56 | Volume | 779,641 |
| Day high | $1.81 | Avg. volume | 781,609 |
| 50-day MA | $1.53 | Dividend yield | N/A |
| 200-day MA | $7.30 | Market Cap | 86.76M |
ALXO Stock Price Chart Interactive Chart >
ALX Oncology Holdings Inc. (ALXO) Company Bio
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.
ALXO Price Returns
| 1-mo | 13.79% |
| 3-mo | -19.90% |
| 6-mo | -82.22% |
| 1-year | -80.12% |
| 3-year | -94.38% |
| 5-year | N/A |
| YTD | -88.92% |
| 2023 | 32.12% |
| 2022 | -47.56% |
| 2021 | -75.07% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...